FDA Safety Communication: Stop using System 83 Plus Automated Endoscope Reprocessors by Custom Ultrasonics, for reprocessing duodenoscopes

6 views
Skip to first unread message

Nauss,Karen A (Mount Auburn)

unread,
Aug 18, 2016, 11:12:58 AM8/18/16
to Alma, Bob Brigham, Jo Wood (jo.wood.m@gmail.com), Julie Hemenway, Nauss,Karen A (Mount Auburn), Mark Duro, Ryan Furtado, Suzanne Setnik (sstefanik@partners.org)

FDA Safety Communication: Stop using System 83 Plus Automated Endoscope Reprocessors by Custom Ultrasonics, for reprocessing duodenoscopes

The FDA is notifying healthcare facilities of Custom Ultrasonics' May 6, 2016 URGENT MEDICAL DEVICE RECALL, and advising users to stop using its System 83 Plus AERs for reprocessing of duodenoscopes.

Based on the Agency's February 2016 Safety Communication, at this time, facilities should have transitioned to alternative methods of reprocessing of duodenoscopes. In addition, FDA is revising its February 2016 Safety Communication to communicate that Custom Ultrasonics' System 83 Plus AERs remain in service for the reprocessing endoscopes other than duodenoscopes.

Because inadequately reprocessed duodenoscopes have been associated with patient infections and death, healthcare facilities should not use Custom Ultrasonics' System 83 Plus AERs for reprocessing duodenoscopes, and should have transitioned to alternative methods of reprocessing these particular endoscopes.

The FDA will continue to provide updates as new information becomes available.

FDA created a website to provide the public with up-to-date information about AERs for which the Agency has reviewed adequate reprocessing validation for duodenoscopes.

The FDA advises healthcare facilities to:

Identify and transition to alternate methods to reprocess duodenoscopes, such as manual high-level disinfection, alternative AERs, liquid chemical sterilization, or other sterilization methods according to the duodenoscope manufacturers' reprocessing instructions.
Regardless of reprocessing method, hospital staff should manually clean duodenoscopes according to the manufacturer's instructions.

Before transitioning to an alternative method, be sure that the duodenoscopes your facility uses are compatible with the alternative method by referring to the duodenoscope manufacturer's reprocessing instructions and the AER manufacturer's instructions.

The FDA continues to recommend the following best practices for all flexible endoscopes:

  • Always clean endoscopes and their accessories thoroughly before high-level disinfection, liquid chemical sterilization, or other sterilization methods.
  • Ensure ready access and promote strict adherence to manufacturer's instructions for cleaning other flexible endoscopes.
  • Implement a comprehensive quality control program for reprocessing flexible endoscopes, including:
  • written procedures for monitoring training and adherence to the program
  • documentation of equipment, tests, processes, and quality monitors used during the reprocessing procedure.
  • Ensure that staff responsible for reprocessing endoscopes understand the importance of their role in reprocessing the device and maintain proficiency in performing required reprocessing tasks.
  • Adhere to general endoscope reprocessing guidelines and practices established by the infection control community and endoscopy professionals.

Read the FDA safety alert.

 




This message is intended for the use of the person(s) to whom it may be addressed. It may contain information that is privileged, confidential, or otherwise protected from disclosure under applicable law. If you are not the intended recipient, any dissemination, distribution, copying, or use of this information is prohibited. If you have received this message in error, please permanently delete it and immediately notify the sender. Thank you.
Reply all
Reply to author
Forward
0 new messages